The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Each Unit Includes One Class A Ordinary Share andOne Share Right to Receive 1/10th of a Class A Ordinary ShareNew York, NY, March 03, 2025 ...

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

MNTN, Inc. (“MNTN”), a technology platform that brings performance marketing to Connected TV, announced that it filed a ...

Real time IPO News in the market. Get the latest headlines and updates in upcoming IPOs. Read the news as it happens.

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

While Kallyope’s drugs are mechanistically unique, the biotech is competing in a crowded space, with other therapies that ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

A special purpose acquisition company is a company formed to raise money through an initial public offering so it can later purchase or merge with an existing company. Special purpose acquisition ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

Fonterra Cooperative Group has announced new developments regarding its global consumer business divestment. This decision ...

On February 3, three insiders purchased a total of around $94.22 million worth of Metsera shares during the company’s initial public offering. Insiders acquired shares at a price of $18 per share. The ...